Lowbica HCT Tablet 5/40/12.5mg

Adult dose

This drug should be taken once daily, with or without food, accompanied by water. It is recommended to take it at the same time each day (e.g., in the morning). The recommended dosages are as follows: - 5/20/12.5mg: To be administered to patients not adequately controlled with the combination therapy of amlodipine/olmesartan medoxomil 5/20mg. - 5/40/12.5mg: To be administered to patients not adequately controlled with the combination therapy of amlodipine/olmesartan medoxomil 5/40mg.

Child dose

The safety and efficacy of this drug in pediatric patients under 18 years of age have not been established, so its use is not recommended.

This drug can cause serious harm to the fetus and newborn if taken during the second or third trimester of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. This drug is contraindicated for patients with an allergy to this drug or its components or with certain heart and kidney diseases, and for those who are pregnant or breastfeeding. It should not be used in patients with very low blood pressure, acute heart issues, or severe liver or kidney disease. Patients with reduced blood volume or impaired renal function may experience hypotension when starting this medication, so monitoring of their condition is necessary. This drug may affect kidney function, requiring regular blood tests for patients with kidney disease or those who have undergone kidney transplantation. Patients with impaired liver function or specific heart valve diseases should also use this drug with caution. The diuretic component in this medication may cause electrolyte imbalances, necessitating regular monitoring of electrolyte levels in the blood. Since blood pressure may drop too low, patients should avoid hazardous activities while taking this medication if they experience dizziness or drowsiness. This drug may interact with other medications, particularly lithium, certain pain relievers, and other antihypertensive agents, so consult a healthcare professional if taking these. The use of this drug is not recommended during breastfeeding, and if necessary, breastfeeding or the drug itself may need to be discontinued. Its safety and efficacy have not been established in pediatric patients under 18 years of age, so its use is not recommended in this population. In elderly patients, starting at a lower dose and careful monitoring is advisable, taking into account impaired kidney and liver function. In case of overdose, symptoms such as hypotension, arrhythmias, and electrolyte imbalances may occur, necessitating immediate medical attention.

Serious side effects

• Urticaria
• peripheral edema
• angioedema
• Quincke's edema
• Stevens-Johnson syndrome
• anaphylactic reactions
• severe swelling (edema)
• chest tightness
• difficulty breathing
• sweating

Mild side effects

• Peripheral edema
• headache
• dizziness
• upper respiratory infections
• nasopharyngitis
• urinary tract infections
• sialadenitis
• leukopenia
• thrombocytopenia
• bone marrow suppression

This drug can deteriorate due to air or moisture, so it must be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1 degree and 30 degrees Celsius.

Appearance

Pale yellow circular film-coated tablet

Package unit

28 tablets (14 tablets/PTP X2) / box